Article in Toxins, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Isabela FerreiraDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto 14040-903, SP, Brazil.ORCID 0000-0002-7424-7132
Isadora OliveiraDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto 14040-903, SP, Brazil.ORCID 0000-0002-2036-1191
Karla BordonDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto 14040-903, SP, Brazil.ORCID 0000-0001-6540-2295
Mouzarllem ReisDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto 14040-903, SP, Brazil.ORCID 0000-0002-7074-6532
Gisele WiezelDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto 14040-903, SP, Brazil.
Caroline SanchezDepartment of Clinical Analysis, Toxicology and Food Science, School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto 14040-903, SP, Brazil.
Luísa SantosInstitute Multidisciplinary in Health, Federal University of Bahia, Vitoria da Conquista 40110-909, BA, Brazil.
Norival Santos-FilhoDepartment of Biochemistry and Organic Chemistry, Chemistry Institute, Sao Paulo State University (UNESP), Araraquara 14800-901, SP, Brazil.ORCID 0000-0002-0344-6900
Manuela PuccaDepartment of Clinical Analysis, Sao Paulo State University (UNESP) Araraquara 14800-901, SP, Brazil.ORCID 0000-0003-2594-7068
Lusânia AntunesDepartment of Clinical Analysis, Toxicology and Food Science, School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto 14040-903, SP, Brazil.ORCID 0000-0002-3079-4388
Daiana LopesInstitute Multidisciplinary in Health, Federal University of Bahia, Vitoria da Conquista 40110-909, BA, Brazil.
Eliane ArantesDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of Sao Paulo, Ribeirao Preto 14040-903, SP, Brazil.ORCID 0000-0002-6712-6033
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
A pioneering study regarding the isolation, biochemical evaluation, functional assays and first PEGylation report of a novel vascular endothelial growth factor from
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Beyond Angiogenesis: The Multitasking Approach of the First PEGylated Vascular Endothelial Growth Factor ( · full record | OpenQuestion